ArticleJournal of experimental & clinical cancer research : CR2026
Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemia.
Jie Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.